Introduction {#ss1}
============

Asthma is one of the most common chronic illnesses worldwide \[[@b1]\]. As of 2011, the World Health Organization (WHO) estimated that globally, around 235 million people suffer from asthma \[[@b1]\]. Many strategies have been employed to decrease asthma related mortality and morbidity \[[@b2]\]. The National Asthma Education and Prevention Program (NAEPP), which was founded by the National Heart, Lung, and Blood Institute (NHLBI), has established guidelines for the proper diagnosis and treatment of asthma \[[@b6]\]. Despite these guidelines, increases in the prevalence, morbidity, mortality and economic burden of asthma have been reported throughout the world \[[@b7]\]. This impacts the physical, emotional and social well-being of sufferers \[[@b1],[@b10]\].

Asthma needs to be recognized as a health priority in the developing world. Increasing urbanization further increases asthma incidence rates with consequent rises in asthma-related morbidity and mortality \[[@b11]\].

Successful management of asthma requires that the physician be cognizant of the national recommendations, including pharmacotherapy and measures to prevent and control exacerbations \[[@b12]\].

Significant differences in the management of asthma are also apparent between specialists and general practitioners (GPs) \[[@b13]\]. GPs play a key role in both identifying poorly controlled asthma and improving disease management outcomes since many asthmatic patients in rural communities are initially seen by them \[[@b5],[@b14]\]. In a recent European study, GPs were experts at excluding those who did not have asthma (specificity 99%), but poorly diagnosed those who had current asthma (sensitivity 59%) \[[@b15]\].

There is a little published information in developing countries describing primary-care physicians' willingness to embrace the guidelines and assess their practice in managing asthma \[[@b16],[@b17]\].

Compositional differences in educational experience among Lebanese GPs may contribute to heterogeneity in treatment strategies \[[@b18]\]. The physician\'s practice in managing asthma must be region-specific to ensure that they are tailored to the needs of a given region \[[@b19]\]. Thus, the aim of this cross-sectional study is to evaluate the current practice of Lebanese GPs in managing asthma.

Materials and methods {#ss2}
=====================

Ethical approval {#ss3}
----------------

Approval from the Institutional Review Board at Makassed General Hospital, Beirut, Lebanon was sought prior to commencement of this cross-sectional survey.

Data sources {#ss4}
------------

Primary data sources utilized in this study were the Lebanese Order of Physicians and the Order of Physicians in North Lebanon. Physicians are unequally distributed between the two professional associations that supervise their practice. One caters for the physicians of North Lebanon, while the four regions are under the Lebanese Order of Physicians. The database of the two orders contained contact information, in addition to the demographic and educational characteristics.

Indeed, to be able to practice in Lebanon, physicians have to be registered with one of these two orders, after passing the same licensure test. There are mechanisms in place to avoid dual registration and to remove physician who no longer practice from the databases. Physicians who are not Lebanese citizens cannot register and therefore cannot practice in Lebanon.

The national census has not been conducted since 1932; this makes recent demographic analysis of Lebanese society a difficult task. Currently, the ratio of physicians to population in Lebanon ranks among the highest in the Eastern Mediterranean region (248 physicians per 100 000 population) \[[@b20]\]. This ratio is characterized by an uneven geographic distribution where the bulk resides in Beirut \[[@b20]\].

Out of 7726 physicians (which included general medicine, internal medicine, pediatrics and obstetrics and gynecology), 2450 were exclusively categorized as GPs. Sampling proportionate to population size of GPs for each district was randomly drawn ([Table 1](#t1){ref-type="table"}). A structured questionnaire was distributed randomly among a representative sample of 330 GPs during a regular assembly of both orders ([Appendix 1](#s1){ref-type="supplementary-material"}).

###### 

Distribution of GPs among regions in Lebanon.[^a^](#T1_1){ref-type="fn"}

  Residency       Population distribution   Sample distribution
  --------------- ------------------------- ---------------------
  Beirut          394 (16)                  53 (16.1)
  Bekaa           612 (25)                  83 (25.1)
  Mount Lebanon   543 (22)                  73 (22.1)
  North           452 (19)                  62 (18.8)
  South           449 (18)                  59 (17.9)
  Total           2450 (100)                330 (100)

Data are presented as number (%).

The questionnaire was constructed on the basis of surveys developed by the NHLBI \[[@b14]\], and the Chicago Asthma Surveillance Initiative Report Team \[[@b21],[@b22]\] to assess the current practice among Lebanese GPs in managing asthma.

Diagnosis of asthma basically depends on clinical assessment (frequency of cough, wheezing, β~2~-agonist use, sleep disturbance and activity level) in addition to laboratory, radiological investigations and pulmonary function testing.

The questionnaire included information ascertaining asthma diagnostic techniques (chest radiography, spirometry, skin testing or radioallergosorbent testing (RAST), daily peak expiratory flow (PEF) monitoring, sinus radiography and sputum exam for eosinophil) used for new asthma patients aged 5 years and above, the clinical monitoring by physicians during regular office visits and the availability or access to spirometry, pharmacotherapeutic approaches to treat asthma, availability of formal patient education program in their clinics, involvement in continuing medical education activities related to asthma, use of asthma practice guideline and demographic characteristics (age, gender, country of medical degree and specialty, year of medical degree graduation and number of asthma patients seen per week).

The validity of the questionnaire was ensured through a pilot sample of 15 GPs who stated that the clarity of the questionnaire was satisfactory with no ambiguity.

Evaluation of asthma treatment was made through two questions: the first was about the medication/s to be used for patients aged 5 years and above with moderate persistent asthma. The second question was in a form of hypothetical clinical scenario: "what are the other medications needed for a patient aged 5 years and above with an uncontrolled asthma maintained on short acting β~2~-agonists inhaler?". Options that included inhaled steroids as mono-therapy or combination were considered as consistent with Global Initiative for Asthma (GINA) guidelines, otherwise were considered inconsistent \[[@b5]\].

Statistical analyses {#ss5}
--------------------

Region (Beirut, Bekaa, Mount Lebanon, North, South)-stratified random sampling was drawn to ensure that the sample was nationally representative. Data analysis was conducted using SAS software (SAS Institute; Cary, NC) to calculate frequency distributions. Means were reported with their corresponding standard deviations (SDs) and frequencies with percentages.

Results {#ss6}
=======

A total of 330 questionnaires were distributed among GPs, of whom 302 completed the questionnaire achieving a response rate of 91.5%.

The characteristics of 302 Lebanese GPs are presented in [Table 2](#t2){ref-type="table"}. Their mean post graduated period was 14.2 ± 6.6 years with small number of female GPs (19%) compared to male GPs (81%). Only 19 (7%) of GPs treated more than 10 asthmatic patients per week.

###### 

Sociodemographic characteristics of GPs participating in the study (*n* = 302).[^a^](#T2_1){ref-type="fn"}

  Characteristics                No. (%) of participants
  ------------------------------ -------------------------
  Age (years)                    40.0 (±6.7)
  Gender:                        
   Male                          245 (81)
   Female                        57 (19)
  Years of practice              14.2 (±6.6)
  Residency                      
   Beirut                        43 (14)
   Bekaa                         76 (25)
   Mount Lebanon                 68 (23)
   North                         57 (19)
   South                         58 (19)
  Medical education graduates    
   Eastern Europe                149 (49.3)
   Lebanon                       70 (23.2)
   Arab countries                39 (12.9)
   Western Europe                25 (8.3)
   Others                        19 (6.3)
  Asthmatic patients in a week   
   1--4 patients                 157 (52)
   5--10 patients                126 (41)
   \>10 patients                 19 (7)

Data are presented as mean (±SD), or number (%).

Evaluation and clinical monitoring of asthma patients {#ss7}
-----------------------------------------------------

For the initial evaluation, chest radiography was the most commonly used diagnostic test by 296 (98.0%) GPs, while sputum exam for eosinophils was the less commonly used diagnostic test (7.9%). Spirometry performed by 142 (47.0%) GPs 3 (0.7%) were performed on site, 139 (46.3%) were performed in specialized centers). In addition, only one GP (0.3%) referred a patient to a specialist for spirometry. In addition, daily peak flow was performed by 63 (20.9%) GPs and 68 (22.5%) GPs referred their patients to allergologist for skin testing or RAST ([Table 3](#t3){ref-type="table"}).

###### 

Asthma diagnostic techniques and clinical monitoring used by participating GPs for asthmatic patients.[^a^](#T3_1){ref-type="fn"}

  Diagnostic techniques               No. (%) of participants
  ----------------------------------- -------------------------
  Chest radiography                   296 (98.0)
  Spirometry                          142 (47.0)
  Skin testing or RAST                68 (22.5)
  Daily peak flow monitoring          63 (20.9)
  Sinus radiography                   33 (10.9)
  Sputum exam for eosinophils         24 (7.9)
  Clinical monitoring                 
  Frequency of cough and wheezing     297 (98.7)
  Frequency of β~2~-agonist use       288 (95.4)
  Frequency of sleep disturbances     215 (71.2)
  Review of inhaler technique         166 (55.0)
  Activity level                      73 (24.2)
  Loss of work/school days            31 (10.3)
  Peak expiratory flow                18 (6.0)
  Peak expiratory flow diary review   9 (3.0)

RAST: radioallergosorbent testing.

Data are presented as number (%).

For clinical monitoring, the presence of cough and wheezing (98.7%) were mostly assessed. Whereas, PEF diary review (3.0%) was rarely monitored ([Table 3](#t3){ref-type="table"}).

Asthma treatment {#ss8}
----------------

Asthma pharmacotherapy approaches are presented in [Table 4](#t4){ref-type="table"}. Two hundred ninety-eight (99%) of GPs prescribed some type of inhalers for asthma treatment. Approximately 38% of GPs prescribed spacer devices, while only 2% of the GPs were uncertain about the safety of inhaled corticosteroids.

###### 

Pharmacotherapeutic approaches reported by participating GPs for patients ≥5 years old with moderate persistent symptoms.[^a^](#T4_1){ref-type="fn"}

  Medications                         Prescribing habits, *n* (%)                             
  ----------------------------------- ----------------------------- ------------ ------------ ------------
  Inhaled short acting β~2~-agonist   285 (94.4)                    12 (4.0)     4 (1.3)      1 (0.3)
  Oral β~2~-agonist                   9 (3.0)                       18 (6.0)     75 (24.8)    200 (66.2)
  LABA                                83 (27.5)                     142 (47.0)   67 (22.2)    10 (3.3)
  Inhaled corticosteroids             264 (87.4)                    26 (8.6)     12 (4.0)     0 (0.0)
  Oral corticosteroids                1 (0.3)                       20 (6.6)     240 (79.5)   41 (13.6)
  Theophylline                        63 (20.9)                     159 (52.6)   70 (23.2)    10 (3.3)
  Leukotriene antagonist              36 (11.9)                     89 (29.5)    120 (39.7)   57 (18.9)
  Cromolyn sodium                     1 (0.3)                       1 (0.3)      50 (16.6)    250 (82.8)
  Oral anti-histamines                8 (2.6)                       40 (13.3)    204 (67.5)   50 (16.6)

LABA = long acting β~2~-agonist.

Data are presented as number (%).

[Table 4](#t4){ref-type="table"} presented the pharmacotherapeutic approaches reported by GPs where short acting inhaled β~2~-agonists were often the most prescribed (94.3%) followed by inhaled corticosteroids (87.4%) then by long acting β-agonist (LABA) and theophylline (27.5% and 20.9%, respectively).

Treatment approach comparison of uncontrolled asthmatics on inhaled short acting β~2~-agonists treatment with GINA recommendations are presented in [Figure 1](#f1){ref-type="fig"} Figure 1.Treatment approach comparison of uncontrolled asthmatics on inhaled short acting β~2~-agonists treatment with GINA recommendations. . Of all, 78.1% prescribed inhaled corticosteroids, of which 44.7% were prescribed alone and the remaining 33.4% were prescribed in combination with one of the followings: LABA, LA, LABA & LA and others.

Patient education and continuous medical education {#ss9}
--------------------------------------------------

Almost 90% of GPs did not provide a formal asthma education program for their patients.

Awareness of the GINA Guidelines was high, with 85% of GPs reporting that they have heard of the guidelines and 72.5% reporting of having read them. Moreover, 65% of GPs reported GINA Guidelines as the most adopted guidelines.

Most of the GPs (72.2%) attended a variety of professional education related to the management of asthma.

Discussion {#ss10}
==========

To understand the current asthma management practice in Lebanon, a nationwide sample of GPs were surveyed to determine their actual asthma practices.

Lebanese GPs practice was consistent with international guidelines for patients ≥5 years old with moderate persistent asthma as inhaled short acting β~2~-agonist was often prescribed (94.4%). However, for uncontrolled asthmatics aged 5 years and above on inhaled short acting β~2~-agonist, our GPs showed lower compatibility with GINA Guidelines as 78.1% prescribed inhaled corticosteroids compared to (95.7%) in Chicago asthma surveillance \[[@b21]\]. Corticosteroids remains the most potent primary controller medication for asthma \[[@b22]\]. Those who were not well controlled on inhaled steroids (33.4%), the addition of LABA or leukotriene antagonists might improve their asthma control \[[@b23]\]. GPs who are inconsistent with GINA Guidelines, still prescribe theophylline (13.6%) over LABA (6%) or leukotriene receptor antagonists (1%). This could be due to the lack of awareness on asthma treatment, or more likely, because theophylline preparations were cheaper than inhalers.

The compliance of GPs with the guidelines showed variability between Asian and European countries \[[@b16],[@b26]\]. In Karachi, Pakistan, a cross-sectional survey conducted by Bhulani et al. found inadequate knowledge of asthma medications among GPs in comparison with the GINA Guidelines and only 10.4% of GPs had adequate practice in asthma management \[[@b16]\]. Similarly, a study by Hussain et al. demonstrated serious deficiencies in the knowledge and attitude of GPs in the management of asthma patients in Pakistan \[[@b26]\]. Moreover, in Genoa, Italy Kryj-Radziszewska et al. found that only 20% of the GPs were able to answer correctly the questions regarding asthma control \[[@b27]\]. However, in Poland, a study by Braido showed a higher GPs compatibility with the guidelines; 42% in the part "General principles of treatment" and 65% in "Pharmacotherapy" \[[@b28]\]. The polish figures are more comparable to our findings.

The present survey showed that PEF monitoring was not commonly used by GPs. This is recommended by GINA Guidelines. Possible limited availability or access to PEF meters may be a factor \[[@b29]\]. When this data was compared to data from Grant et al. \[[@b21]\], the utilization of PEF was much less among our GPs (20.9% versus 47.5%).

Our ratios of ordering spirometry (47%) and RAST (22%) were comparable to Chicago asthma surveillance (54.6% and 14.1%, respectively) \[[@b21]\]. Similarly, the sputum examination and stain for eosinophilia rates were comparable between Lebanon and Chicago (7.9% versus 5%, respectively). The RAST has a sensitivity of 70--75% for the detection of allergen-specific IgE \[[@b30]\]. Increase in sputum eosinophils as a predictor of airway inflammation is often seen in patients with asthma \[[@b31]\]. In some cases, patients with uncontrolled asthma and airway hyper-responsiveness (PC~20~ \<4 mg/ml) demonstrated an increase in sputum eosinophils to a median of 4.5% \[[@b32]\], but this observation has not been consistently demonstrated \[[@b33]\].

The perception of strict asthma control has evolved over the past years. While the goals set by GINA \[[@b5]\] and NAEPP \[[@b34]\] Guidelines seem unrealistic and unachievable for some clinicians, but meticulous monitoring, treatment and education can make it possible \[[@b35]\]. We were able to identify important aspects of asthma monitoring in Lebanon that were divergent to the international guidelines. Activity levels and loss of work or school days due to asthma were not routinely asked by GPs (24.2% and 10.3%, respectively). GPs are not expected to comply with the use of spirometry as it is not included in their routine practice which was clearly reflected in our findings.

Patient education is an essential component of asthma care. Our survey showed that patients warrant better education about asthma as only 10% had previous asthma education program. This could be related to limited availability or awareness of this program.

Conclusion {#ss11}
==========

Based on current international guidelines, the overall Lebanese GPs practice of asthma management is not at an acceptable standard. Therefore, it is recommended to improve monitoring parameters, implement the asthma guidelines nationally and improve patient education.
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